
Enzolytics Inc.
OTC:ENZC
0.02 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Enzolytics Inc. |
Symbool | ENZC |
Munteenheid | USD |
Prijs | 0.022 |
Beurswaarde | 53,065,461 |
Dividendpercentage | 0% |
52-weken bereik | 0.016 - 0.132 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Charles S. Cotropia |
Website | https://enzolytics.com |
An error occurred while fetching data.
Over Enzolytics Inc.
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)